Wolverine Asset Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-101,713
Closed -$5.7K – 2169
2023
Q3
$5.7K Hold
101,713
– – ﹤0.01% 1545
2023
Q2
$15K Hold
101,713
– – ﹤0.01% 1334
2023
Q1
$9.66K Hold
101,713
– – ﹤0.01% 1456
2022
Q4
$10.2K Hold
101,713
– – ﹤0.01% 1628
2022
Q3
$8K Hold
101,713
– – ﹤0.01% 2072
2022
Q2
$14K Sell
101,713
-1,130
-1% -$211 ﹤0.01% 1909
2022
Q1
$23K Buy
+102,843
New +$26.7K ﹤0.01% 1737

Wolverine Asset Management's BIOSW Position: Q4 2023 in Review

Wolverine Asset Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 101,713 shares — an estimated $5.7K sold.

Wolverine Asset Management first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $23K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

  • Wolverine Asset Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 101,713 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $5.7K.
  • Wolverine Asset Management first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
  • Wolverine Asset Management's BioPlus Acquisition Corp. Warrants position peaked at $23K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Wolverine Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.